Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.

Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma. Oncology (Williston Park). 2004 May; 18(5):623-30; discussion 633-4, 637-8, 640.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.